{"content":"<li class=\"n-box-item date-title\" data-end=\"1485838799\" data-start=\"1485752400\" data-txt=\"Sunday, December 22, 2019\">Monday, January 30, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3238924\" data-ts=\"1485822703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SANM\" target=\"_blank\">SANM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238924-sanminaplus-10_5-q1-2017-outlook-for-q2-confident\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanmina +10.5%; Q1 2017, outlook for Q2 confident</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3238820-sanmina-beats-0_08-beats-revenue\" target=\"_blank\">Q1 2017 results</a></strong> &ndash; revenue $1.72B (+12.4% Y/Y,&nbsp;<font color='green'>$30M above estimates</font>), EPS $0.75 (<font color='green'>$0.08 above estimates</font>), operating margin 4.2%, operating income $71.7M (vs. $61M Y/Y), net income $57.7M (vs. $46.8M Y/Y), cash flow from operations $53.9M, ending cash and cash equivalents $405.2M, inventory turns 6.6x, cash cycle days 40.4</li><li><strong>Q2 2017 projections</strong> &ndash; revenue $1.675B-$1.725B (<a href=\"https://finance.yahoo.com/quote/SANM/analysts?p=SANM\" target=\"_blank\">consensus $1.65B</a>), EPS $0.67-$0.72 (consensus $0.65).</li><li>Sanmina (NASDAQ:<a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a>)&nbsp;chairman and CEO Jure Sola: \"Solid execution and growth in our end-markets were key drivers for our improved financial results in the quarter. Revenue was up 3 percent sequentially and 12 percent year over year. Our value-added services, diversified markets and innovative technologies are key differentiators for Sanmina which allow us to capitalize on opportunities with new and existing customers. Based on our results for the first quarter and our outlook for the second quarter, we are optimistic that fiscal 2017 will be another growth year.\"</li><li><a href=\"http://ir.sanmina.com/phoenix.zhtml?p=irol-eventDetails&amp;c=69249&amp;eventID=5247085\" target=\"_blank\">Conference call</a></li><li><a href=\"https://seekingalpha.com/pr/16727191-sanmina-reports-first-quarter-fiscal-2017-results\" target=\"_blank\">Press release</a></li><li><a href=\"http://media.corporate-ir.net/media_files/IROL/69/69249/Q1\" target=\"_blank\">Presentation</a></li><li><a href=\"https://seekingalpha.com/filing/3375433\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238924\" data-linked=\"Sanmina +10.5%; Q1 2017, outlook for Q2 confident\" data-tweet=\"$SANM - Sanmina +10.5%; Q1 2017, outlook for Q2 confident https://seekingalpha.com/news/3238924-sanminaplus-10_5-q1-2017-outlook-for-q2-confident?source=tweet\" data-url=\"https://seekingalpha.com/news/3238924-sanminaplus-10_5-q1-2017-outlook-for-q2-confident\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238922\" data-ts=\"1485822569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238922-new-residential-prices-49m-share-offering-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Residential prices 49M-share offering at $15</a></h4><ul>   <li>New Residential Investment Corp. (<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a> <font color='red'>-3.8%</font>) priced its previously announced public offering of stock <a href=\"https://seekingalpha.com/pr/16727463-new-residential-announces-pricing-public-offering-common-stock\" target=\"_blank\">at $15/share</a>.</li>    <li>It's offering just over 49.17M shares in order to help <a href=\"https://seekingalpha.com/news/3238621-new-residential-cuts-another-msr-deal-hints-blowout-q4-hikes-dividend-sets-capital-raise\" target=\"_blank\">fund its mortgage servicing rights deal with CitiMortgage</a>.</li>    <li>The offering's expected to close on Friday.</li>    <li>Joint book-runners are Citigroup Global markets, Barclays Capital, BofA Merrill Lynch and Credit Suisse Securities.</li>    <li>Shares declined to $15.66 today; after hours, <a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a> is <font color='red'>down another 1.5%</font> to $15.42.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238922\" data-linked=\"New Residential prices 49M-share offering at $15\" data-tweet=\"$NRZ - New Residential prices 49M-share offering at $15 https://seekingalpha.com/news/3238922-new-residential-prices-49m-share-offering-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3238922-new-residential-prices-49m-share-offering-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238918\" data-ts=\"1485820618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238918-split-tops-a-dogs-purpose-to-lead-box-office-for-second-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Split&#39; tops &#39;A Dog&#39;s Purpose&#39; to lead box office for second week</a></h4><ul>   <li><i>Split</i> (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-0.8%</font>) reigned for a second straight week at the box office, topping another new entry from the same studio as well as the resilient <i>Hidden Figures.</i></li>    <li><i>A Dog's Purpose</i> -- like <i>Split,</i> also a Universal film -- drew $18.2M to trail <i>Split's</i> $25.7M. Along with No. 7 film <i>Sing</i> ($6.4M), Universal had three of the top 10 films at the box office this weekend.</li>    <li>Meanwhile, <i>Hidden Figures</i> (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+0.4%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.3%</font>) showed legs with $14M and the No. 3 spot. The Oscar-nominated film crossed $104M in domestic grosses in its sixth week of release.</li>    <li>The top five was rounded out by newcomer <i>Resident Evil: The Final Chapter</i> (<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> <font color='red'>-3.5%</font>) at No. 4 with $13.6M, and <i>La La Land</i> (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-0.5%</font>), taking $12.2M (and crossing $106M in domestic grosses itself).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238918\" data-linked=\"&#39;Split&#39; tops &#39;A Dog&#39;s Purpose&#39; to lead box office for second week\" data-tweet=\"$FOX $FOX $FOXA - &#39;Split&#39; tops &#39;A Dog&#39;s Purpose&#39; to lead box office for second week https://seekingalpha.com/news/3238918-split-tops-a-dogs-purpose-to-lead-box-office-for-second-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3238918-split-tops-a-dogs-purpose-to-lead-box-office-for-second-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238915\" data-ts=\"1485820115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238915-evercore-starts-t-mobile-buy-carrier-rivals-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore starts T-Mobile at Buy, carrier rivals at Hold</a></h4><ul>   <li>T-Mobile (<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='red'>-2.1%</font>) got another vote of confidence in a tough U.S. wireless market, as Evercore launched the company at Buy (and its Big Four rivals at Hold).</li>    <li>&ldquo;TMUS has the <a href=\"http://blogs.barrons.com/techtraderdaily/2017/01/30/t-mobile-the-only-buy-for-evercore-in-u-s-telecoms-rough-neighborhood/\" target=\"_blank\">best growth prospects in the space</a>, driven by strong branding, product innovation, and improved network performance and coverage,\" says analyst Vijay Jayant. &ldquo;It&rsquo;s also the most likely to benefit from sector consolidation or wireless M&amp;A from outside the telecom sector, as it provides a potential acquirer the opportunity to add a business that is strong on a standalone basis, and a digestible size.&rdquo;</li>    <li>Meanwhile, pricing (with discounts of 10-30%) plays an advantage for T-Mobile and Sprint (<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='red'>-1.2%</font>) vs. bigger rivals AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-0.5%</font>) and Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='red'>-0.5%</font>), he says. \"Prices, adjusted for data included, have trended downward over time. Both T and VZ still have substantial portions of their subscriber bases on subsidy plans, and those customers continue to migrate to newer, lower-cost plans.\"</li>    <li>Jayant has a price target of $72 on TMUS, implying 18% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238915\" data-linked=\"Evercore starts T-Mobile at Buy, carrier rivals at Hold\" data-tweet=\"$TMUS $TMUS $S - Evercore starts T-Mobile at Buy, carrier rivals at Hold https://seekingalpha.com/news/3238915-evercore-starts-t-mobile-buy-carrier-rivals-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/3238915-evercore-starts-t-mobile-buy-carrier-rivals-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238916\" data-ts=\"1485820027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238916-dryshipsplus-35-ah-following-kalani-stock-purchase-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips +35% AH following Kalani stock purchase agreement</a></h4><ul>     <li>DryShips (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>) <font color='green'>+34.9%</font>&nbsp;AH after <a href=\"https://seekingalpha.com/filing/3375905\" target=\"_blank\">disclosing</a> more information related to its Dec. 23 sale of more than 22.5M shares to Kalani Investments; shares already had rallied 23% in <a href=\"https://seekingalpha.com/news/3238784-dryships-bounces-post-split-low\" target=\"_blank\">regular trading</a>.</li>     <li>DRYS says it sold more than 31M shares to Kalani between Dec. 23 and Jan. 30 at an average price of ~$6.30/share for a total of $200M.</li><li>CNBC's Karen Finerman <a href=\"https://twitter.com/CNBCFastMoney/status/826205977838047232\" target=\"_blank\">says</a>:&nbsp;\"Kalani Investments may have already sold [the shares] to the public... They haven't made that particularly clear... So if you're buying it because you think somebody just bought $200M worth of stock - no. I think they were selling it to who they hoped would be the bigger fools.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238916\" data-linked=\"DryShips +35% AH following Kalani stock purchase agreement\" data-tweet=\"$DRYS - DryShips +35% AH following Kalani stock purchase agreement https://seekingalpha.com/news/3238916-dryshipsplus-35-ah-following-kalani-stock-purchase-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3238916-dryshipsplus-35-ah-following-kalani-stock-purchase-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238907\" data-ts=\"1485817299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238907-integrated-device-technologyminus-4_16-q3-2017-okay-q4-forecast-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Integrated Device Technology -4.16%; Q3 2017 okay, Q4 forecast light</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3238823-integrated-device-tech-beats-0_01-beats-revenue\" target=\"_blank\">Q3 2017 results</a></strong> &ndash; revenue $176.4M (-0.7% Y/Y,&nbsp;<font color='green'>$0.24M above estimates</font>), EPS $0.35 (<font color='green'>$0.01 above estimates</font>), net income $49M (vs. $47.4M Q/Q, $52.2M Y/Y), gross profit $108.7M (vs. $111.4M Q/Q, $111.1M Y/Y), R&amp;D expense $33.5M (vs. $35.3M Q/Q, $33.8M Y/Y), SG&amp;A expense $25.7M (vs. $28.2M Q/Q, $25.1M Y/Y)</li><li><strong>Q4 2017 projections</strong> &ndash; revenue $170M-$180M (<a href=\"https://finance.yahoo.com/quote/IDTI/analysts?p=IDTI\" target=\"_blank\">consensus $179.43M</a>), EPS $0.32-$0.36 (consensus $0.35)</li><li>Integrated Device Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a>) president and CEO Gregory Waters: \"Third quarter fiscal 2017 revenue totaled $176.4 million, slightly better than the midpoint of our prior guidance range, on strength in sensing solutions sold into our Consumer end market. We have increasing momentum in multiple new growth areas, particularly automotive, industrial, and sensors, that will drive future growth. Additionally, we remain disciplined in managing our operating model, delivering best-in-class profitability and earnings leverage.\"</li><li><a href=\"http://edge.media-server.com/m/p/nd67zfiu\" target=\"_blank\">Conference call</a></li><li><a href=\"https://seekingalpha.com/pr/16727195-idt-reports-q3-fiscal-year-2017-financial-results\" target=\"_blank\">Press release</a></li><li><a href=\"http://files.shareholder.com/downloads/IDTI/3766444547x0x925704/081E4814-F3D3-4863-BA73-3304EF7DC41C/IDTI_3Q17_Financial_Webcast_Slides.pdf\" target=\"_blank\">Presentation</a></li><li><a href=\"https://seekingalpha.com/filing/3375544\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238907\" data-linked=\"Integrated Device Technology -4.16%; Q3 2017 okay, Q4 forecast light\" data-tweet=\"$IDTI - Integrated Device Technology -4.16%; Q3 2017 okay, Q4 forecast light https://seekingalpha.com/news/3238907-integrated-device-technologyminus-4_16-q3-2017-okay-q4-forecast-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3238907-integrated-device-technologyminus-4_16-q3-2017-okay-q4-forecast-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238897\" data-ts=\"1485815906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238897-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='green'>+8.5%</font>. <a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='green'>+5.9%</font>. <a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='green'>+4.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color='red'>-12.7%</font>. <a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-10.2%</font>. <a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a> <font color='red'>-4.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238897\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SANM $WERN $AEIS - After Hours Gainers / Losers https://seekingalpha.com/news/3238897-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3238897-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238896\" data-ts=\"1485815752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEIS\" target=\"_blank\">AEIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238896-advanced-energy-pops-5-on-q4-earnings-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Energy pops more than 5% on Q4 earnings, strong guidance</a></h4><ul><li>Advanced Energy Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a>) <font color='green'>+5.6%</font>&nbsp;AH&nbsp;after posting a strong <a href=\"https://seekingalpha.com/news/3238828-advanced-energy-beats-0_25-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat and a 56% Y/Y revenue increase, and guiding Q1 earnings and revenues above consensus.</li><li>AEIS sees Q1 EPS of $0.90-$1.00 vs. $0.80 analyst consensus estimate, revenues of $141M-$151M vs. $129M consensus, and operating margins of 29%-31%.</li><li>AEIS says its Q4 semiconductor and service revenues reached new highs, more than  offsetting a decline in industrial applications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238896\" data-linked=\"Advanced Energy pops more than 5% on Q4 earnings, strong guidance\" data-tweet=\"$AEIS - Advanced Energy pops more than 5% on Q4 earnings, strong guidance https://seekingalpha.com/news/3238896-advanced-energy-pops-5-on-q4-earnings-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3238896-advanced-energy-pops-5-on-q4-earnings-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238893\" data-ts=\"1485815009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238893-rambus-q4-2016-okay-q1-2017-revenue-midpoint-projected-below-consensus-q1-2017-eps-roughly-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rambus Q4 2016 okay, Q1 2017 revenue midpoint projected below consensus, Q1 2017 EPS roughly in line; -3.08%</a></h4><ul>     <li><strong><a href=\"https://seekingalpha.com/news/3238849-rambus-eps-line-beats-revenue\" target=\"_blank\">Q4 2016 results</a></strong> &ndash; revenue $97.56M (+27.1% Y/Y,&nbsp;<font color='green'>$1.56M above estimates</font>), EPS $0.16 (in line), operating costs and expenses $67.5M (+11% Q/Q, +56% Y/Y), net income $18.7M (+4% Q/Q, -10% Y/Y), cash, cash equivalents, and marketable securities $172.2M (+$21.4M from September 30, 2016), income tax provision approximately $0.9M</li><li><strong>Q1 2017 projections</strong> &ndash; revenue $93M-$98M (<a href=\"https://finance.yahoo.com/quote/RMBS/analysts?p=RMBS\" target=\"_blank\">consensus $96M</a>), EPS $0.13-$0.17 (consensus $0.16), operating costs and expenses $67M-$70M</li><li>Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a>) CEO Dr. Rob Black: \"Our activity throughout 2016 has prepared us well for profitable growth moving into 2017. Our memory and interfaces business continues to perform well with the ability to accelerate our customer engagements for the data center. We also have several avenues of exciting opportunities to extend beyond our historic business, particularly as we move closer to the consumer with offerings serving the mobile edge.\"</li><li><strong>After hours</strong> &ndash; Shares volatile.</li><li><a href=\"http://edge.media-server.com/m/p/88ozjg73\" target=\"_blank\">Conference call</a></li><li><a href=\"https://www.rambus.com/fourth-quarter-and-fiscal-year-2016-financial-results/\" target=\"_blank\">Press release</a></li><li><a href=\"https://seekingalpha.com/filing/3375660\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238893\" data-linked=\"Rambus Q4 2016 okay, Q1 2017 revenue midpoint projected below consensus, Q1 2017 EPS roughly in line; -3.08%\" data-tweet=\"$RMBS - Rambus Q4 2016 okay, Q1 2017 revenue midpoint projected below consensus, Q1 2017 EPS roughly in line; -3.08% https://seekingalpha.com/news/3238893-rambus-q4-2016-okay-q1-2017-revenue-midpoint-projected-below-consensus-q1-2017-eps-roughly-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3238893-rambus-q4-2016-okay-q1-2017-revenue-midpoint-projected-below-consensus-q1-2017-eps-roughly-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238877\" data-ts=\"1485813115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMLP\" target=\"_blank\">SMLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238877-summit-midstream-partners-in-4m-unit-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit Midstream Partners in 4M-unit secondary offering</a></h4><ul>     <li>Summit Midstream Partners (NYSE:<a href='https://seekingalpha.com/symbol/SMLP' title='Summit Midstream Partners'>SMLP</a>) <font color='red'>-4.4%</font>&nbsp;AH after announcing a <a href=\"https://seekingalpha.com/pr/16727267-summit-midstream-partners-lp-announces-secondary-public-offering-common-units-summit\" target=\"_blank\">secondary public offering</a> of 4M common units by selling shareholder Summit Midstream Partners Holdings, a wholly owned direct subsidiary of sponsor Summit Midstream Partners LLC.</li><li>SMP  Holdings has granted the underwriter an option to purchase up to  an  additional 600K common units.</li><li>SMLP will not receive any proceeds from the offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238877\" data-linked=\"Summit Midstream Partners in 4M-unit secondary offering\" data-tweet=\"$SMLP - Summit Midstream Partners in 4M-unit secondary offering https://seekingalpha.com/news/3238877-summit-midstream-partners-in-4m-unit-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3238877-summit-midstream-partners-in-4m-unit-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238869\" data-ts=\"1485812489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHT\" target=\"_blank\">DHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238869-dht-holdings-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DHT Holdings beats by $0.07, beats on revenue</a></h4><ul><li>DHT Holdings (NYSE:<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a>): Q4 EPS of $0.18 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $67M (-16.2% Y/Y) <font color='green'>beats by $1.27M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16727297-dht-holdings-inc-fourth-quarter-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238869\" data-linked=\"DHT Holdings beats by $0.07, beats on revenue\" data-tweet=\"$DHT - DHT Holdings beats by $0.07, beats on revenue https://seekingalpha.com/news/3238869-dht-holdings-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3238869-dht-holdings-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238855\" data-ts=\"1485811502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOFI\" target=\"_blank\">BOFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238855-bofiplus-1_2-after-fq2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofI +1.2% after FQ2 results</a></h4><ul><li>FQ2 income of $32.2M or $0.50 per share vs. $28M and $0.44 one year ago.</li><li>Tangible book value of $11.72 per share vs. $9.60 a year earlier.</li><li>Total assets of $8.17B up 22.6% Y/Y, with loan and lease portfolio up 20.7%.</li><li>Loan and lease provision of $4.1M vs. $3.4M a year earlier, mostly thanks to loan growth.</li><li>Deposits up 27.1% Y/Y.</li><li><a href=\"http://www.bofiholding.com\" target=\"_blank\">Conference call</a> at 5 ET</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238818-bofi-holding-eps-0_50\" target=\"_blank\">BofI Holding EPS of $0.50</a> (Jan. 30)</li><li><a href='https://seekingalpha.com/symbol/BOFI' title='BofI Holding, Inc.'>BOFI</a>&nbsp;<font color='green'>+1.2%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3238855\" data-linked=\"BofI +1.2% after FQ2 results\" data-tweet=\"$BOFI - BofI +1.2% after FQ2 results https://seekingalpha.com/news/3238855-bofiplus-1_2-after-fq2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3238855-bofiplus-1_2-after-fq2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238843\" data-ts=\"1485811122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIGL\" target=\"_blank\">RIGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238843-rigel-readies-equity-offering-shares-ease-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rigel readies equity offering; shares ease 9% after hours</a></h4><ul><li>Rigel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a>) slumps&nbsp;<font color='red'>9%</font>&nbsp;after hours on average volume in response to its <a href=\"https://seekingalpha.com/pr/16727185-rigel-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcement </a>of a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238843\" data-linked=\"Rigel readies equity offering; shares ease 9% after hours\" data-tweet=\"$RIGL - Rigel readies equity offering; shares ease 9% after hours https://seekingalpha.com/news/3238843-rigel-readies-equity-offering-shares-ease-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3238843-rigel-readies-equity-offering-shares-ease-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238830\" data-ts=\"1485810500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMHC\" target=\"_blank\">TMHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238830-taylor-morrison-down-3_2-on-stock-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taylor Morrison down 3.2% on stock sale</a></h4><ul><li>The company<a href=\"https://seekingalpha.com/pr/16727197-taylor-morrison-home-corporation-announces-public-offering-class-common-stock\" target=\"_blank\"> is selling 10M shares</a> of common stock with underwriter greenshoe of 1.5M shares.</li><li>Proceeds will be used to cash out a number of P-E holders of the company.</li><li><a href='https://seekingalpha.com/symbol/TMHC' title='Taylor Morrison'>TMHC</a>&nbsp;<font color='red'>-3.2%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3238830\" data-linked=\"Taylor Morrison down 3.2% on stock sale\" data-tweet=\"$TMHC - Taylor Morrison down 3.2% on stock sale https://seekingalpha.com/news/3238830-taylor-morrison-down-3_2-on-stock-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3238830-taylor-morrison-down-3_2-on-stock-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238828\" data-ts=\"1485810427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEIS\" target=\"_blank\">AEIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238828-advanced-energy-beats-0_25-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Energy beats by $0.25, beats on revenue</a></h4><ul><li>Advanced Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a>): Q4 EPS of $1.06 <font color='green'>beats by $0.25</font>.</li><li>Revenue of $135.3M (+55.7% Y/Y) <font color='green'>beats by $4.16M</font>.</li><li>Shares <font color='green'>+4.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16727214-advanced-energy-announces-fourth-quarter-full-year-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238828\" data-linked=\"Advanced Energy beats by $0.25, beats on revenue\" data-tweet=\"$AEIS - Advanced Energy beats by $0.25, beats on revenue https://seekingalpha.com/news/3238828-advanced-energy-beats-0_25-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3238828-advanced-energy-beats-0_25-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238825\" data-ts=\"1485810333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPR\" target=\"_blank\">BPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238825-general-growth-properties-ffo-and-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Growth Properties FFO and revenue in-line</a></h4><ul><li>General Growth Properties (GGP): Q4 FFO of $0.43 in-line.</li><li>Revenue of $610.34M (-5.3% Y/Y) in-line.</li><li>Shares <font color='green'>+2.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16727181-ggp-reports-fourth-quarter-2016-results-declares-first-quarter-dividend\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238825\" data-linked=\"General Growth Properties FFO and revenue in-line\" data-tweet=\"$BPR - General Growth Properties FFO and revenue in-line https://seekingalpha.com/news/3238825-general-growth-properties-ffo-and-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3238825-general-growth-properties-ffo-and-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238816\" data-ts=\"1485809927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238816-akorn-slumps-7-on-fda-ok-of-new-ephedrine-competitor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akorn slumps 7% on FDA OK of new ephedrine competitor</a></h4><ul><li>The market's down day notwithstanding, Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='red'>-6.6%</font>) heads south over investors' concerns over new ephedrine sulfate competitor Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+0.2%</font>), whose Corphedra was just approved by the FDA under its accelerated pathway.</li><li>Akorn's top seller is ephedrine sulfate, accounting for 23% of Q3 revenue and about a third of its gross profit. Another competitor, Avadel Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a> <font color='red'>-7%</font>), formerly Flamel Technologies, has been grabbing market share, now as high as 30%.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3238816\" data-linked=\"Akorn slumps 7% on FDA OK of new ephedrine competitor\" data-tweet=\"$AKRX $AKRX $ENDP - Akorn slumps 7% on FDA OK of new ephedrine competitor https://seekingalpha.com/news/3238816-akorn-slumps-7-on-fda-ok-of-new-ephedrine-competitor?source=tweet\" data-url=\"https://seekingalpha.com/news/3238816-akorn-slumps-7-on-fda-ok-of-new-ephedrine-competitor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238813\" data-ts=\"1485809267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHL\" target=\"_blank\">AHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238813-rough-session-for-insurers-after-aspen-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for insurers after Aspen warns</a></h4><ul><li>Weak <a href=\"https://seekingalpha.com/news/3238724-aspen-insurance-holdings-lower-3-percent-announcing-underwriting-results\" target=\"_blank\">preliminary results </a>from Aspen Insurance (<a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='red'>-2.3%</font>) signals worsening commercial &nbsp;insurance fundamentals and likely means continuing consolidation is necessary, says Barclays' Jay Gelb.</li><li>Bloomberg notes all but one of the 55 members of the S&amp;P insurance index are in the red, with AHL near the top of the list of underperformers. Other laggards include: Kemper (<a href='https://seekingalpha.com/symbol/KMPR' title='Kemper Corporation'>KMPR</a> <font color='red'>-2.5%</font>), United Insurance (<a href='https://seekingalpha.com/symbol/UIHC' title='United Insurance Holdings Corp.'>UIHC</a> <font color='red'>-2.8%</font>), RLI Corp (<a href='https://seekingalpha.com/symbol/RLI' title='RLI Corp'>RLI</a> <font color='red'>-2.1%</font>), and Brown &amp; Brown (<a href='https://seekingalpha.com/symbol/BRO' title='Brown & Brown Insurance'>BRO</a> <font color='red'>-2.1%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/KIE' title='SPDR S&P Insurance ETF'>KIE</a>, <a href='https://seekingalpha.com/symbol/IAK' title='iShares U.S. Insurance ETF'>IAK</a>, <a href='https://seekingalpha.com/symbol/KBWP' title='Invesco KBW Property & Casualty Insurance Portfolio ETF'>KBWP</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238813\" data-linked=\"Rough session for insurers after Aspen warns\" data-tweet=\"$AHL $AHL $KMPR - Rough session for insurers after Aspen warns https://seekingalpha.com/news/3238813-rough-session-for-insurers-after-aspen-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/3238813-rough-session-for-insurers-after-aspen-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238812\" data-ts=\"1485809039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238812-trump-travel-ban-puts-20b-in-boeing-aircraft-sales-risk-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump travel ban puts $20B in Boeing aircraft sales at risk, analyst says</a></h4><ul>     <li>Pres. Trump's immigration action targeting countries such as Iran and Iraq <a href=\"http://www.cnbc.com/2017/01/30/trump-immigration-ban-puts-20-billion-in-boeing-aircraft-sales-to-iran-iraq-at-risk.html\" target=\"_blank\">places at risk</a> ~$20B worth of Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-1.5%</font>) commercial aircraft orders, says CFRA&nbsp;Research aerospace analyst James Corridore.</li><li>Boeing's order book is strong enough to withstand potential cancellations, but there's also a risk that Trump's tough talk on China trade  could threaten the company's aircraft sales to that country and result in  sales going to Airbus (<a href='https://seekingalpha.com/symbol/EADSF' title='Airbus SE'>OTCPK:EADSF</a>, <a href='https://seekingalpha.com/symbol/EADSY' title='Airbus SE ADR'>OTCPK:EADSY</a>), Corridore says.</li><li>Last month, Boeing announced a $16.6B deal for state-owned Iran Air to buy 50 of its narrow-body 737 passenger jets and  30 of the wide-body 777 aircraft; also, Iraq has firm orders to  buy 10 of Boeing's 787 Dreamliner wide-body aircraft and another 18 of  the 737s.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238812\" data-linked=\"Trump travel ban puts $20B in Boeing aircraft sales at risk, analyst says\" data-tweet=\"$BA $BA $EADSF - Trump travel ban puts $20B in Boeing aircraft sales at risk, analyst says https://seekingalpha.com/news/3238812-trump-travel-ban-puts-20b-in-boeing-aircraft-sales-risk-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3238812-trump-travel-ban-puts-20b-in-boeing-aircraft-sales-risk-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238811\" data-ts=\"1485808870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238811-laidlaw-likes-evoke-sees-189-upside-shares-ahead-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Laidlaw likes Evoke, sees 189% upside; shares ahead 12%</a></h4><ul><li>Laidlaw upgrades Evoke Pharma (<a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+11.7%</font>) to Buy from Neutral with an $8 (189% upside) price target based on an improved outlook for Gimoti in moderate-to-severe diabetic gastroparesis.</li><li>Analyst Yale Jen cites positive late-stage clinical data and the FDA's suggestion that only an additional positive pharmacokinetic study (versus 10 mg of Reglan) would be needed for an NDA filing.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3238811\" data-linked=\"Laidlaw likes Evoke, sees 189% upside; shares ahead 12%\" data-tweet=\"$EVOK - Laidlaw likes Evoke, sees 189% upside; shares ahead 12% https://seekingalpha.com/news/3238811-laidlaw-likes-evoke-sees-189-upside-shares-ahead-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3238811-laidlaw-likes-evoke-sees-189-upside-shares-ahead-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238808\" data-ts=\"1485807851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238808-noble-corp-upgraded-to-buy-rowan-cut-to-hold-jefferies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. upgraded to Buy, Rowan cut to Hold at Jefferies</a></h4><ul><li>Noble Corp. (<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='red'>-7.2%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/01/30/offshore-drillers-here-we-go-again/\" target=\"_blank\">upgraded to Buy</a> from Hold with a $9.50 price target while offshore drilling peer Rowan (<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='red'>-8.1%</font>) is downgraded to Hold from Buy with a $20 target at Jefferies.</li><li>While the firm still does not view the group favorably, it sees relative value in NE and considers the stock as the safest way to play offshore drilling exposure for now, as the stock should enjoy modest upside on a distributable cash flow and relative valuation basis.</li><li>Meanwhile, although RDC still generates healthy free cash flow, Jefferies sees risk that medium-term earnings disappoint as the upturn in jackups and ultra-deepwater markets looks challenged from a profitability standpoint.</li><li>The group is taking a beating today amid broad losses in energy stocks: <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='red'>-9%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-8%</font>, <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='red'>-7.7%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-7.5%</font>, <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-7.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238808\" data-linked=\"Noble Corp. upgraded to Buy, Rowan cut to Hold at Jefferies\" data-tweet=\"$NE $NE $RDC - Noble Corp. upgraded to Buy, Rowan cut to Hold at Jefferies https://seekingalpha.com/news/3238808-noble-corp-upgraded-to-buy-rowan-cut-to-hold-jefferies?source=tweet\" data-url=\"https://seekingalpha.com/news/3238808-noble-corp-upgraded-to-buy-rowan-cut-to-hold-jefferies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238802\" data-ts=\"1485806408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238802-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+16%</font>. NQ <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-17%</font>. MSDI <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238802\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$DGLY $LKM $CRNT - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3238802-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3238802-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238800\" data-ts=\"1485805704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAH\" target=\"_blank\">BAH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238800-booz-allenminus-6_5-after-bottom-line-miss-light-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Booz Allen -6.5% after bottom line miss, light guidance</a></h4><ul><li>FQ3 adjusted net income of $56.6M fell from $61.8M one year earlier; EPS of $0.38 fell from $0.41. Expectations were for $0.40. It's all about costs as revenue of $1.4B topped estimates for $1.37B.</li><li>Backlogs grew to $13.5B from $12.1B a year ago.</li><li>Full-year FQ17 guidance for revenue growth is lifted to 4-6%. Adjusted EPS, however, is seen at $1.70-$1.74 vs. the Street at $1.74.</li><li>The quarterly dividend is hiked to $0.17 from $0.15.</li><li>Cowen just hit the tape, calling today's selloff overblown.</li><li><a href='https://seekingalpha.com/symbol/BAH' title='Booz Allen Hamilton Holding Corporation'>BAH</a>&nbsp;<font color='red'>-6.5%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3238598-booz-allen-declares-0_17-dividend\" target=\"_blank\">Booz Allen declares $0.17 dividend</a> (Jan. 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238599-booz-allen-misses-0_02-beats-revenue\" target=\"_blank\">Booz Allen misses by $0.02, beats on revenue</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3238800\" data-linked=\"Booz Allen -6.5% after bottom line miss, light guidance\" data-tweet=\"$BAH - Booz Allen -6.5% after bottom line miss, light guidance https://seekingalpha.com/news/3238800-booz-allenminus-6_5-after-bottom-line-miss-light-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3238800-booz-allenminus-6_5-after-bottom-line-miss-light-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238794\" data-ts=\"1485804047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238794-bangladesh-to-bid-for-chevron-gas-fields\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bangladesh to bid for Chevron gas fields</a></h4><ul>     <li>Bangladesh <a href=\"http://www.reuters.com/article/us-bangladesh-chevron-idUSKBN15E1X3\" target=\"_blank\">will make a formal offer</a> for Chevron's (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-2%</font>) three natural gas fields in the country after reserves and other details have been assessed, its energy minister tells Reuters.</li><li>The energy-starved country meets half of its gas needs through the CVX-operated fields at Bibiyana, Jalalabad and Moulavi Bazar, highlighting their importance for the poor  country.</li>     <li>CVX said last year it was in discussions about the potential sale of the three fields with an estimated value of $2B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238794\" data-linked=\"Bangladesh to bid for Chevron gas fields\" data-tweet=\"$CVX - Bangladesh to bid for Chevron gas fields https://seekingalpha.com/news/3238794-bangladesh-to-bid-for-chevron-gas-fields?source=tweet\" data-url=\"https://seekingalpha.com/news/3238794-bangladesh-to-bid-for-chevron-gas-fields\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238791\" data-ts=\"1485803716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238791-energy-materials-top-gainers-losers-of-2-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:15 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/CETC' title='Clean Enviro Tech Corp.'>CETC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EEP' title='Enbridge Energy Partners L.P.'>EEP</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238791\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:15 pm\" data-tweet=\"$ESES-OLD $CETC $CELP - Energy/Materials - Top Gainers / Losers as of 2:15 pm https://seekingalpha.com/news/3238791-energy-materials-top-gainers-losers-of-2-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3238791-energy-materials-top-gainers-losers-of-2-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238787\" data-ts=\"1485801935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238787-sears-holdingsminus-13-after-sale-leaseback-deal-cbl\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears Holdings -13% after sale-leaseback deal with CBL</a></h4><ul><li>Sears Holdings (SHLD) is&nbsp;<font color='red'>down 13%&nbsp;</font>after the company <a href=\"https://seekingalpha.com/symbol/SHLD/key-data/filings\" target=\"_blank\">discloses </a>a sale-leaseback deal with CBL &amp;&nbsp;Associates for five department stores and two auto stores at CBL malls.</li><li>Earlier this month, Moody's warned on the ability of Sears to meet its cash burn even with the asset sales accelerating.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238715-cbl-and-associates-sale-leaseback-deal-five-sears-stores\" target=\"_blank\">CBL &amp; Associates in sale-leaseback deal for five Sears stores</a> (Jan. 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3236488-moodys-downgrades-sears-amid-ongoing-cash-burn\" target=\"_blank\">Moody's downgrades Sears amid ongoing cash burn</a> (Jan. 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238410-downward-spiral-continues-sears-holdings\" target=\"_blank\">Downward spiral continues on Sears Holdings</a> (Jan. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3238787\" data-linked=\"Sears Holdings -13% after sale-leaseback deal with CBL\" data-tweet=\"$SHLDQ - Sears Holdings -13% after sale-leaseback deal with CBL https://seekingalpha.com/news/3238787-sears-holdingsminus-13-after-sale-leaseback-deal-cbl?source=tweet\" data-url=\"https://seekingalpha.com/news/3238787-sears-holdingsminus-13-after-sale-leaseback-deal-cbl\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238780\" data-ts=\"1485800082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238780-fitbit-target-lowered-to-6_50-mizuho-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit target lowered to $6.50 at Mizuho Securities</a></h4><ul><li>From $9 (current price $6.09), <a href=\"http://www.streetinsider.com/Analyst+Comments/Fitbit+%28FIT%29+PT+Lowered+to+%246.50+at+Mizuho+Securities/12473721.html\" target=\"_blank\">analyst Betty Chen</a> notes that despite Fitbit's (<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-15.5%</font>) lead positioning in wearables and forecasted $2.70 cash per share at the end of Q4, declining category growth, possible saturation within the U.S. and soft adoption internationally signal lower unit demand and ASP pressure for the foreseeable future.</li><li>Further expects lack of revenue visibility to contribute to ongoing share strain.</li><li>Neutral rating maintained.</li><li>Earlier (January 30, 2017): <a href=\"https://seekingalpha.com/news/3238697-fitbit-minus-11_8-percent-q4-2016-preliminary-results-fy-2017-outlook-significantly\" target=\"_blank\">Fitbit -11.8%; Q4 2016 preliminary results, FY 2017 outlook significantly below expectations</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238780\" data-linked=\"Fitbit target lowered to $6.50 at Mizuho Securities\" data-tweet=\"$FIT - Fitbit target lowered to $6.50 at Mizuho Securities https://seekingalpha.com/news/3238780-fitbit-target-lowered-to-6_50-mizuho-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3238780-fitbit-target-lowered-to-6_50-mizuho-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238925\" data-ts=\"1485799639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTU\" target=\"_blank\">BTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238925-peabody-energy-sees-2016-revenue-totaling-least-4_71b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peabody Energy sees 2016 revenue totaling at least $4.71B</a></h4><ul>     <li>Peabody Energy (BTUUQ <font color='green'>+18.6%</font>) <a href=\"https://seekingalpha.com/filing/3373990\" target=\"_blank\">discloses</a> that it expects 2016 total revenue to come in at $4.71B-$4.72B, with adjusted EBITDA of $482M-$502M.</li>     <li>BTU says 2016 revenues reflect pricing and volume declines driven by the coal industry downturn, but results rebounded in H2, driven by higher natural gas prices and increased demand.</li>     <li>BTU says it ended 2016 with an $872M cash balance, more than 3x higher than year-end 2015, reflecting higher revenue and ongoing cost savings.</li>     <li>Also, BTU expects to have sold 187M tons of coal in 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238925\" data-linked=\"Peabody Energy sees 2016 revenue totaling at least $4.71B\" data-tweet=\"$BTU - Peabody Energy sees 2016 revenue totaling at least $4.71B https://seekingalpha.com/news/3238925-peabody-energy-sees-2016-revenue-totaling-least-4_71b?source=tweet\" data-url=\"https://seekingalpha.com/news/3238925-peabody-energy-sees-2016-revenue-totaling-least-4_71b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238777\" data-ts=\"1485799402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238777-europe-closes-out-worst-session-in-three-months\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Europe closes out worst session in three months</a></h4><ul><li>The news probably isn't the Stoxx 600&nbsp;<font color='red'>retreating 1.1%&nbsp;</font>today, but that markets have been so good of late that a 1% decline stands as the biggest fall since prior to the election.</li><li>All 19 Stoxx 600 sectors fell, with the banks<font color='red'> lower by 1.7%</font>.</li><li>As for individual countries, Italy (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWI' title='iShares MSCI Italy Capped ETF'>EWI</a>) -&nbsp;<font color='red'>off 2.95%</font>&nbsp;- led the way down as it works <a href=\"https://seekingalpha.com/news/3238549-italy-fund-room-recapitalize-banks\" target=\"_blank\">on a bank recapitalization plan</a>. Spain (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWP' title='iShares MSCI Spain Capped ETF'>EWP</a>)&nbsp;<font color='red'>fell 1.5%</font>, France (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWQ' title='iShares MSCI France ETF'>EWQ</a>) and Germany (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWG' title='iShares MSCI Germany ETF'>EWG</a>)&nbsp;<font color='red'>1.1%</font>, and the U.K. (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>)&nbsp;<font color='red'>0.9%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VGK' title='Vanguard FTSE Europe ETF'>VGK</a>, <a href='https://seekingalpha.com/symbol/HEDJ' title='WisdomTree Europe Hedged Equity ETF'>HEDJ</a>, <a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>, <a href='https://seekingalpha.com/symbol/IEV' title='iShares Europe ETF'>IEV</a>, <a href='https://seekingalpha.com/symbol/EPV' title='ProShares UltraShort FTSE Europe ETF'>EPV</a>, <a href='https://seekingalpha.com/symbol/EZU' title='iShares MSCI Eurozone ETF'>EZU</a>, <a href='https://seekingalpha.com/symbol/FEU' title='SPDR STOXX Europe 50 ETF'>FEU</a>, <a href='https://seekingalpha.com/symbol/EURL' title='Direxion Daily FTSE Europe Bull 3x Shares ETF'>EURL</a>, <a href='https://seekingalpha.com/symbol/DBEU' title='Deutsche X-trackers MSCI Europe Hedged Equity ETF'>DBEU</a>, <a href='https://seekingalpha.com/symbol/EEA' title='European Equity Fund'>EEA</a>, <a href='https://seekingalpha.com/symbol/FEP' title='First Trust Europe AlphaDEX ETF'>FEP</a>, <a href='https://seekingalpha.com/symbol/HEZU' title='iShares Currency Hedged MSCI EMU ETF'>HEZU</a>, <a href='https://seekingalpha.com/symbol/UPV' title='ProShares Ultra FTSE Europe ETF'>UPV</a>, <a href='https://seekingalpha.com/symbol/IEUR' title='iShares Core MSCI Europe ETF'>IEUR</a>, <a href='https://seekingalpha.com/symbol/FEEU' title='Barclays ETN+ FI Enhanced Europe 50 ETN'>FEEU</a>, <a href='https://seekingalpha.com/symbol/ADRU' title='BLDRS Europe 100 ADR Index ETF'>ADRU</a>, <a href='https://seekingalpha.com/symbol/EUFN' title='iShares MSCI Europe Financials Sector Index ETF'>EUFN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238777\" data-linked=\"Europe closes out worst session in three months\" data-tweet=\"$EWI $EWP $EWQ - Europe closes out worst session in three months https://seekingalpha.com/news/3238777-europe-closes-out-worst-session-in-three-months?source=tweet\" data-url=\"https://seekingalpha.com/news/3238777-europe-closes-out-worst-session-in-three-months\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238775\" data-ts=\"1485799209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238775-financials-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BANC' title='Banc of California, Inc.'>BANC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CFBK' title='Central Federal Corporation'>CFBK</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPB' title='Opus Bank'>OPB</a> <font color='red'>-23%</font>. PBIB <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FNLC' title='First Bancorp, Inc &#40;ME&#41;'>FNLC</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238775\" data-linked=\"Financials - Gainers / Losers as of 1:00 PM\" data-tweet=\"$AIII $BANC $CFBK - Financials - Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3238775-financials-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3238775-financials-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238774\" data-ts=\"1485799124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAA\" target=\"_blank\">PAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238774-plains-all-american-started-neutral-mizuho-mostly-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plains All American started at Neutral by Mizuho, mostly on valuation</a></h4><ul>     <li>Plains All American Pipeline (<a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='red'>-2.9%</font>) and Plains GP&nbsp;(<a href='https://seekingalpha.com/symbol/PAGP' title='Plains GP Holdings, LP'>PAGP</a> <font color='green'>+0.3%</font>) are initiated with Neutral ratings (<a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+Plains+All+American+%28PAA%29+at+Neutral/12471327.html\" target=\"_blank\">I</a>, <a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Starts+Plains+GP+Holdings%2C+L.P+%28PAGP%29+at+Neutral/12471331.html\" target=\"_blank\">II</a>) and respective price targets of $34 and $35 at Mizuho, which says visibility is supported by rising Permian crude oil volume,  contributions from contracted organic projects and a low cost of capital  from corporate simplification.</li><li>The firm notes PAGP's healthy 6.8% dividend  yield and Permian crude oil infrastructure exposure through a C-corp  structure, which deserves a modest premium to PAA, but its enthusiasm is tempered by valuation, leverage and competition.</li><li>Mizuho thinks part of  the Permian growth story is baked into PAA and PAGP, which have risen  by a respective 67% and 57% over the past year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238774\" data-linked=\"Plains All American started at Neutral by Mizuho, mostly on valuation\" data-tweet=\"$PAA $PAA $PAGP - Plains All American started at Neutral by Mizuho, mostly on valuation https://seekingalpha.com/news/3238774-plains-all-american-started-neutral-mizuho-mostly-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3238774-plains-all-american-started-neutral-mizuho-mostly-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238766\" data-ts=\"1485798296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238766-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+49%</font>. <a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/AIRI' title='Air Industries Group, Inc.'>AIRI</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='red'>-68%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-49%</font>. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/OPB' title='Opus Bank'>OPB</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='red'>-14%</font>. MSDI <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238766\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CALA $RGSE $ESES-OLD - Midday Gainers / Losers https://seekingalpha.com/news/3238766-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3238766-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238755\" data-ts=\"1485795636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238755-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/STS' title='Supreme Industries, Inc'>STS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238755\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$TPX $NAKD $NVFY - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3238755-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3238755-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238753\" data-ts=\"1485795359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238753-freeport-may-soon-get-temporary-export-permit-indonesia-minister-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport may soon get temporary export permit, Indonesia minister says</a></h4><ul>     <li>Indonesia's government <a href=\"http://www.reuters.com/article/us-indonesia-freeport-idUSKBN15E1X7\" target=\"_blank\">may issue a temporary mining permit</a> \"in one or two days\" to Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='red'>-1.6%</font>), the mining minister says, potentially enabling the company to resume exports of copper concentrate from its Grasberg mine in Papua.</li>     <li>The minister says the government is now processing a proposal from FCX and may issue a temporary special mining permit for up to six months to avoid a stoppage to the company's exports while it completes the requirements for a new special mining permit.</li>     <li>Indonesia halted FCX's exports of concentrate <a href=\"https://seekingalpha.com/news/3234910-freeport-mcmoran-miners-halt-indonesian-exports\" target=\"_blank\">on Jan. 12</a> when a ban on shipping unprocessed ore out of the country took effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238753\" data-linked=\"Freeport may soon get temporary export permit, Indonesia minister says\" data-tweet=\"$FCX - Freeport may soon get temporary export permit, Indonesia minister says https://seekingalpha.com/news/3238753-freeport-may-soon-get-temporary-export-permit-indonesia-minister-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3238753-freeport-may-soon-get-temporary-export-permit-indonesia-minister-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238748\" data-ts=\"1485794439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238748-banks-lead-decline-on-wall-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banks lead decline on Wall Street</a></h4><ul><li>The <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> and <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> are each<font color='red'> down more than 2%&nbsp;</font>vs. the S&amp;P 500's&nbsp;<font color='red'>1% retreat</font>.</li><li>Pick your excuse, but the best explanation is probably seen in the sharp upward and to the right price charts of the banking sector names, and the occasional need to take a breath.</li><li>There's also politics, and Treasury Secretary nominee Steven Mnuchin over the weekend&nbsp;<a href=\"https://www.bloomberg.com/politics/articles/2017-01-28/mnuchin-dims-banks-hopes-he-will-allow-a-prop-trading-revival\" target=\"_blank\">provided more evidence</a> that the Trump administration intends to tweak, but not gut Dodd-Frank. At issue is the Volcker Rule which prohibits lenders from taking risky bets with federally-insured deposits.</li><li>Mnuchin in a letter to lawmakers: \"A legal distinction between the insured and non-insured entity is an important factor ...&nbsp;I do not believe that the uninsured entity should be able to perform proprietary trading.\"</li><li>Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-2.4%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-1.7%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-1.4%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-2.1%</font>), U.S. Bancorp (<a href='https://seekingalpha.com/symbol/USB' title='U.S. Bancorp'>USB</a> <font color='red'>-0.9%</font>), Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='red'>-1.5%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='red'>-2.3%</font>), Fifth Third (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color='red'>-2.3%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3238748\" data-linked=\"Banks lead decline on Wall Street\" data-tweet=\"$BAC $KBE $KRE - Banks lead decline on Wall Street https://seekingalpha.com/news/3238748-banks-lead-decline-on-wall-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3238748-banks-lead-decline-on-wall-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238744\" data-ts=\"1485793309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEM\" target=\"_blank\">SEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238744-select-medicalminus-6_7-wells-fargo-throws-in-towel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Medical -6.7% as Wells Fargo throws in the towel</a></h4><ul><li>It's day two of big losses for Select Medical (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='red'>-6.7%</font>) following Friday's <a href=\"https://seekingalpha.com/pr/16725579-b-select-b-b-medical-b-holdings-corporation-announces-estimate-results-fourth-quarter-year\" target=\"_blank\">disappointing preliminary Q4 results</a>.</li><li>Wondering why the company didn't set the bar lower for this year after falling short of guidance in both 2015 and 2016, Wells' Gary Lieberman downgrades to Market Perform from Outperform. High staffing levels, he says, might mean more time is needed to achieve any operating leverage.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238744\" data-linked=\"Select Medical -6.7% as Wells Fargo throws in the towel\" data-tweet=\"$SEM - Select Medical -6.7% as Wells Fargo throws in the towel https://seekingalpha.com/news/3238744-select-medicalminus-6_7-wells-fargo-throws-in-towel?source=tweet\" data-url=\"https://seekingalpha.com/news/3238744-select-medicalminus-6_7-wells-fargo-throws-in-towel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238745\" data-ts=\"1485793301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238745-veterans-group-to-support-standing-rock-protesters-against-dakota-access\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veterans group to support Standing Rock protesters against Dakota Access</a></h4><ul><li>A military veterans group says it is <a href=\"http://www.cnbc.com/2017/01/30/veterans-raise-funds-for-standing-rock-after-trump-dakota-access-memo.html\" target=\"_blank\">raising funds</a> to support the  Standing Rock Sioux tribe and protesters who oppose completion  of Energy Transfer Partners' (ETP <font color='red'>-1.8%</font>) Dakota Access pipeline.</li><li>The group, called Veterans Stand, says its efforts include developing the capability to deploy thousands of veteran volunteers to the area; it claims ~4K veterans traveled to the reservation in North Dakota last  month to support the protest against the pipeline.</li><li>Veterans Stand says it is responding to Pres.&nbsp;Trump's executive order <a href=\"https://seekingalpha.com/news/3237079-trump-signs-executive-orders-push-keystone-dakota-pipelines\" target=\"_blank\">last week</a> pushing the project's development and because \"turmoil and  uncertainty at Standing Rock has increased significantly\" in the last  two weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238745\" data-linked=\"Veterans group to support Standing Rock protesters against Dakota Access\" data-tweet=\"$ET - Veterans group to support Standing Rock protesters against Dakota Access https://seekingalpha.com/news/3238745-veterans-group-to-support-standing-rock-protesters-against-dakota-access?source=tweet\" data-url=\"https://seekingalpha.com/news/3238745-veterans-group-to-support-standing-rock-protesters-against-dakota-access\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238739\" data-ts=\"1485792389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDC\" target=\"_blank\">MDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238739-meritage-homes-and-m-d-c-holdings-lead-homebuilders-lower-after-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meritage Homes and M.D.C. Holdings lead homebuilders lower after downgrades</a></h4><ul><li>Investor sentiment has about peaked, says Evercore ISI's Stephen Kim, downgrading M.D.C. Holdings (<a href='https://seekingalpha.com/symbol/MDC' title='M.D.C. Holdings, Inc.'>MDC</a> <font color='red'>-3.2%</font>) to Sell and Meritage Homes (<a href='https://seekingalpha.com/symbol/MTH' title='Meritage Homes Corporation'>MTH</a> <font color='red'>-2.6%</font>) to Hold.</li><li>A lot of good news is priced into the names, he says, but he expects gross margins to slim this year thanks to rising costs for wages, materials, and land.</li><li>As for new policies out of D.C., any benefit from lower taxes is likely to be offset by tougher immigration enforcement and import tariffs.</li><li>Kim prefers D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='red'>-1.8%</font>) and Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='red'>-2.3%</font>) thanks to strong ROEs, deleveraging, and spec-building strategies.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3238739\" data-linked=\"Meritage Homes and M.D.C. Holdings lead homebuilders lower after downgrades\" data-tweet=\"$MDC $MDC $MTH - Meritage Homes and M.D.C. Holdings lead homebuilders lower after downgrades https://seekingalpha.com/news/3238739-meritage-homes-and-m-d-c-holdings-lead-homebuilders-lower-after-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3238739-meritage-homes-and-m-d-c-holdings-lead-homebuilders-lower-after-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238737\" data-ts=\"1485792135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238737-capstone-reports-preliminary-fq3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone reports preliminary FQ3 results</a></h4><ul><li>In an effort to increase investor transparency, Capstone Turbine (<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='green'>+8.1%</font>) announced preliminary FQ3 results indicating that cash usage decreased 56% on a 35% increase in revenue from the prior quarter.</li><li>In addition, the company said that net product orders increased, inventory levels decreased and that it set a new record for Factory Protection Plan service contract backlog.</li><li>More details <a href=\"https://seekingalpha.com/pr/16726572-capstone-turbine-reports-preliminary-third-quarter-fiscal-2017-financial-results\" target=\"_blank\">here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238737\" data-linked=\"Capstone reports preliminary FQ3 results\" data-tweet=\"$CPST - Capstone reports preliminary FQ3 results https://seekingalpha.com/news/3238737-capstone-reports-preliminary-fq3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3238737-capstone-reports-preliminary-fq3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238705\" data-ts=\"1485791991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238705-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+53%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='red'>-68%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-45%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VAR' title='Varian Medical Systems, Inc.'>VAR</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238705\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$CALA $EYEG $CBAY - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3238705-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3238705-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238735\" data-ts=\"1485791985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238735-chevron-to-give-ceo-fewer-stock-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron to give CEO fewer stock options</a></h4><ul>     <li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-2.1%</font>) says it will give CEO&nbsp;John Watson <a href=\"http://www.reuters.com/article/us-chevron-compensation-idUSKBN15E187\" target=\"_blank\">fewer stock options</a> after shareholders expressed concern about executive pay.</li>     <li>CVX's board approved a grant to Watson that included 250K stock options, 65,340 performance shares and 32,670 restricted stock units in 2017, compared  with 964.8K stock options and 73.6K performance shares in 2016.</li>     <li>CVX says the average support from  shareholders for its compensation package fell to 54% in 2016 from the 95% it averaged during 2011-15.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238735\" data-linked=\"Chevron to give CEO fewer stock options\" data-tweet=\"$CVX - Chevron to give CEO fewer stock options https://seekingalpha.com/news/3238735-chevron-to-give-ceo-fewer-stock-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3238735-chevron-to-give-ceo-fewer-stock-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238729\" data-ts=\"1485791255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238729-u-s-stocks-retreat-busy-week-ramps-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. stocks retreat as busy week ramps up</a></h4><ul>     <li>U.S. stocks are lower following a flurry of new developments with the Trump administration's policies and ahead of a barrage of earnings and economic releases later this week. There's also a Fed meeting to factor in.</li>     <li>The S&amp;P 500 Index is <font color='red'>down 0.99%</font> and the Dow is <font color='red'>off 0.92%</font>, sliding below 20K&nbsp;on the way.&nbsp;&nbsp;Small caps are quivering more than the big boys, with the Russell 2000 Index&nbsp;<font color='red'>down 1.82%</font>. The oil and gas sector is notably lower as crude oil swings back below $53.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238729\" data-linked=\"U.S. stocks retreat as busy week ramps up\" data-tweet=\"U.S. stocks retreat as busy week ramps up https://seekingalpha.com/news/3238729-u-s-stocks-retreat-busy-week-ramps-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3238729-u-s-stocks-retreat-busy-week-ramps-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238727\" data-ts=\"1485791081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238727-bristow-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow on the move</a></h4><ul><li>Bristow (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) starts the week in the red, <font color='red'>falling 7%</font> in early trade.</li><li>Shares are <font color='red'>down 16%</font> since the beginning of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238727\" data-linked=\"Bristow on the move\" data-tweet=\"$BRS - Bristow on the move https://seekingalpha.com/news/3238727-bristow-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3238727-bristow-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238721\" data-ts=\"1485790369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238721-latest-nrz-deal-looks-pricey-piper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latest NRZ deal looks pricey - Piper</a></h4><ul><li>New Residential's (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>) deal for $97B UPB of MSRs from CitiMortgage appears more expensive than its recent purchases from Walter Investment and PHH, says Piper's Kevin Barker.</li><li>The Citi acquisition price is 0.98% of UPB vs. Walter at 0.71% and PHH at 0.85%. In part, this reflects higher valuations of late for MSRs thanks to the big rise in interest rates.</li><li>Also part of the Citi sale, <a href=\"https://seekingalpha.com/news/3238630-citigroup-getting-mortgage-servicing-business\" target=\"_blank\">was the transfer</a> of some subservicing to Cenlar, a move which could be beneficial to Black Knight Financial (<a href='https://seekingalpha.com/symbol/BKFS' title='Black Knight Financial Services'>BKFS</a> <font color='red'>-1.2%</font>), says Piper's Jason Deleeuw.</li><li>Source: Bloomberg</li><li>Considering the sizable secondary to fund the purchase, NRZ is hanging in there today,&nbsp;<font color='red'>down just 0.1%</font>.</li><li>The \"high price\" for Citi's MSRs would seemingly be good news for Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) and its stable of servicing rights, but it's&nbsp;<font color='red'>lower by 3.2%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238621-new-residential-cuts-another-msr-deal-hints-blowout-q4-hikes-dividend-sets-capital-raise\" target=\"_blank\">New Residential cuts another MSR deal, hints at blowout Q4, hikes dividend, sets capital raise</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3238721\" data-linked=\"Latest NRZ deal looks pricey - Piper\" data-tweet=\"$NRZ $NRZ $BKFS - Latest NRZ deal looks pricey - Piper https://seekingalpha.com/news/3238721-latest-nrz-deal-looks-pricey-piper?source=tweet\" data-url=\"https://seekingalpha.com/news/3238721-latest-nrz-deal-looks-pricey-piper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238708\" data-ts=\"1485789631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238708-eyegate-pharmas-ocular-bandage-gel-shows-positive-effect-in-pilot-study-shares-ahead-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate Pharma&#39;s ocular bandage gel shows positive effect in pilot study; shares ahead 15%</a></h4><ul><li>Thinly traded nano cap EyeGate Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+15.3%</font>) shrugs off the market's down day on almost a 10x surge in volume. This morning, the company <a href=\"https://seekingalpha.com/pr/16726573-eyegate-pharma-announces-positive-top-line-data-first-human-pilot-trial-ocular-bandage-gel\" target=\"_blank\">announced </a>positive top-line data from a first-in-human pilot study assessing the effect of its EyeGate Ocular Bandage Gel &#40;OBG&#41;&nbsp;in accelerating the re-epithelialization of large corneal epithelial defects in patients who have undergone photorefractive keratectomy (laser surgery to correct nearsightedness).</li><li>Results showed 75.0% (n=9/12) of patients in arm 1 of the study (received EyeGate OBG four times/day for two weeks after surgery) achieved complete wound closure by day 3 versus 53.8% for standard-of-care (could be a transposition error since 53.8% of 12 = ~6.5; 58.3% = 7). In addition, the average wound area on day 1 post surgery was about 1/2 the size in the EyeGate OBG group compared to standard-of-care [artificial tears and a bandage contact lens &#40;BLC&#41;].</li><li>The company plans to initiate a double-masked controlled trial comparing EyeGate OBC to BCL in Q2.</li><li>The EyeGate OBG is a clear viscous hydrogel eye drop that coats the ocular surface with little or no optical blur and is designed to resist degradation. The company says the prolonged residence time of the bandage on the ocular surface overcomes the limitations of current cross-linked hyaluronic acid formulations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238708\" data-linked=\"EyeGate Pharma&#39;s ocular bandage gel shows positive effect in pilot study; shares ahead 15%\" data-tweet=\"$EYEG - EyeGate Pharma&#39;s ocular bandage gel shows positive effect in pilot study; shares ahead 15% https://seekingalpha.com/news/3238708-eyegate-pharmas-ocular-bandage-gel-shows-positive-effect-in-pilot-study-shares-ahead-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3238708-eyegate-pharmas-ocular-bandage-gel-shows-positive-effect-in-pilot-study-shares-ahead-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238717\" data-ts=\"1485789428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238717-mega-order-boosts-digital-ally-sharesplus-9_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mega order boosts Digital Ally shares +9.6%</a></h4><ul><li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color='green'>soars 9.6%</font> in early trade after American Medical Response <a href=\"https://seekingalpha.com/pr/16726554-american-medical-response-awards-digital-ally-largest-commercial-order-history\" target=\"_blank\">awarded</a> the company the largest commercial order in its history.</li><li>The initial order for deployment during 2017 includes approximately 1,550 three-camera DVM-250 systems, installation and cloud storage services, representing 2017 revenues approximating $2M. Shipments will begin immediately.</li><li>AMR also plans to deploy DVM-250 event recorders in its full fleet of 6,500-plus vehicles during 2018 and 2019, which would increase the potential total contract value to over $8.3M during the three-year deployment period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238717\" data-linked=\"Mega order boosts Digital Ally shares +9.6%\" data-tweet=\"$DGLY - Mega order boosts Digital Ally shares +9.6% https://seekingalpha.com/news/3238717-mega-order-boosts-digital-ally-sharesplus-9_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3238717-mega-order-boosts-digital-ally-sharesplus-9_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238713\" data-ts=\"1485788546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYW\" target=\"_blank\">SKYW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238713-u-s-airline-stocks-tilt-lower-after-weekend-protests\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. airline stocks tilt lower after weekend protests</a></h4><ul> <li>Airline stocks are lower after a weekend of protests at U.S. airports tied to President Trump's ban on immigration from certain nations.</li> <li>Analysts expect the protests (and Delta's short system outage) to end up being rounding errors to revenue, although it does layer on a new risk factor.</li> <li>\"We&rsquo;re more concerned about the widespread protests which will likely foster business travel book-away as travelers look to avoid travel at some of the largest airports in the country,\" warns Buckingham Research (source: Bloomberg).</li><li>Decliners include SkyWest (<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color='red'>-4.4%</font>), Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='red'>-2.1%</font>), Allegiant Travel (<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a> <font color='red'>-2%</font>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='red'>-1.8%</font>), JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='red'>-2%</font>), United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='red'>-3.9%</font>), American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='red'>-4.9%</font>), Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-3.1%</font>) and Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a> <font color='red'>-1.3%</font>).</li> <li>Related ETF: <a href='https://seekingalpha.com/symbol/JETS' title='U.S. Global Jets ETF'>JETS</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238713\" data-linked=\"U.S. airline stocks tilt lower after weekend protests\" data-tweet=\"$SKYW $SKYW $ALK - U.S. airline stocks tilt lower after weekend protests https://seekingalpha.com/news/3238713-u-s-airline-stocks-tilt-lower-after-weekend-protests?source=tweet\" data-url=\"https://seekingalpha.com/news/3238713-u-s-airline-stocks-tilt-lower-after-weekend-protests\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238706\" data-ts=\"1485788116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238706-harmony-gold-guides-for-strong-h2-2016-earnings-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmony Gold guides for strong H2 2016 earnings growth</a></h4><ul>     <li>Harmony Gold (<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+2.3%</font>) opens higher after disclosing an <a href=\"https://seekingalpha.com/filing/3373984\" target=\"_blank\">H2 2016 guidance update</a> for EPS of ZAR 1.39-1.60, which is 235%-255% higher than the headline loss of ZAR 103 cents/share reported for  the year-ago period.</li>     <li>In U.S. dollar terms, headline EPS are seen at $0.10-$0.11/share, or 230%-255% higher than the headline loss  of $0.08 reported for the year-ago period.</li>     <li>HMY cites an increase in the average gold spot price received, the recognition of a gain on the Hidden Valley acquisition, and gains recognized in gold and currency hedges.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238706\" data-linked=\"Harmony Gold guides for strong H2 2016 earnings growth\" data-tweet=\"$HMY - Harmony Gold guides for strong H2 2016 earnings growth https://seekingalpha.com/news/3238706-harmony-gold-guides-for-strong-h2-2016-earnings-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3238706-harmony-gold-guides-for-strong-h2-2016-earnings-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238701\" data-ts=\"1485787440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIBB\" target=\"_blank\">HIBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238701-hibbett-sports-on-move-after-goldman-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hibbett Sports on the move after Goldman upgrades</a></h4><ul> <li>Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+2%</font>) bounces nicely at the open after Goldman Sachs <a href=\"https://www.marketbeat.com/stocks/NASDAQ/HIBB/?\" target=\"_blank\">upgrades</a> to Neutral from Sell.</li> <li>The investment firm thinks industry consolidation in the sporting goods sector could help Hibbett.</li> <li>Shares of Hibbett are down 10% YTD amid broad concerns in the retail sector.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3238701\" data-linked=\"Hibbett Sports on the move after Goldman upgrades\" data-tweet=\"$HIBB - Hibbett Sports on the move after Goldman upgrades https://seekingalpha.com/news/3238701-hibbett-sports-on-move-after-goldman-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3238701-hibbett-sports-on-move-after-goldman-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238697\" data-ts=\"1485787139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238697-fitbitminus-11_8-q4-2016-preliminary-results-fy-2017-outlook-significantly-below-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit -11.8%; Q4 2016 preliminary results, FY 2017 outlook significantly below expectations</a></h4><ul><li><strong>Preliminary Q4 2016 results</strong> &ndash; revenue $572M-$580M (prior guide $725M-$750M, <a href=\"https://finance.yahoo.com/quote/FIT/analysts?p=FIT\" target=\"_blank\">consensus $738.16M</a>), net loss per share -$0.51 to -$0.56 (prior guide $0.14-$0.18, consensus $0.17), gross margin \"materially below\" prior 46% forecast, devices sold 6.5M</li><li><strong>Preliminary FY 2017 projections</strong> &ndash; revenue $1.5B-$1.7B (consensus $3.9B), net loss per share -$0.22 to -$0.44 (consensus $0.64), free cash flow -$50M to -$100M, gross margin 45% (vs. prior 50% expectation)</li><li><strong>Workforce reorganization</strong> &ndash; Reducing global workforce by approximately 6% (110 employees), cost of which is projected at $4M for Q1 2017.</li><li>Targets $200M decrease (to approximately $850M) of 2016 exit operating expense for 2017 through realignment of sales and marketing spend and better optimization of R&amp;D investments.</li><li>Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>)&nbsp;$6.36.</li><li><a href=\"https://seekingalpha.com/pr/16726733-fitbit-announces-preliminary-fourth-quarter-2016-results\" target=\"_blank\">Press release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238697\" data-linked=\"Fitbit -11.8%; Q4 2016 preliminary results, FY 2017 outlook significantly below expectations\" data-tweet=\"$FIT - Fitbit -11.8%; Q4 2016 preliminary results, FY 2017 outlook significantly below expectations https://seekingalpha.com/news/3238697-fitbitminus-11_8-q4-2016-preliminary-results-fy-2017-outlook-significantly-below-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3238697-fitbitminus-11_8-q4-2016-preliminary-results-fy-2017-outlook-significantly-below-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238691\" data-ts=\"1485786052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIGL\" target=\"_blank\">RIGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238691-rigels-fostamatinib-still-positive-in-late-stage-extension-study-shares-ahead-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rigel&#39;s fostamatinib still positive in late-stage extension study; shares ahead 11% premarket</a></h4><ul><li>Rigel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16726411-fostamatinib-study-results-continue-trend-positive\" target=\"_blank\">announcement </a>of a sustained treatment benefit in patients with chronic immune thrombocytopenic purpura &#40;ITP&#41; receiving fostamatinib in a long-term Phase 3 extension study (Study 049).</li><li>Responders from earlier trials (Study 047, Study 048) who enrolled in Study 049 (n=17) have maintained a median platelet count of 106,500/uL (median treatment period = 16 months). In addition, 22% (n=9/41) of patients treated with fostamatinib for a minimum of 12 weeks achieved a stable platelet response.</li><li><a href=\"http://www.rigel.com/index.php/fostamatinib-itp/\" target=\"_blank\">Fostamatinib&nbsp;</a>inhibits an enzyme called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Syk\" target=\"_blank\">spleen tyrosine kinase</a>&nbsp;&#40;SYK&#41; which plays a key role in certain blood cancers and autoimmune disorders.</li><li>The company intends to file a marketing application in the U.S. this quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238691\" data-linked=\"Rigel&#39;s fostamatinib still positive in late-stage extension study; shares ahead 11% premarket\" data-tweet=\"$RIGL - Rigel&#39;s fostamatinib still positive in late-stage extension study; shares ahead 11% premarket https://seekingalpha.com/news/3238691-rigels-fostamatinib-still-positive-in-late-stage-extension-study-shares-ahead-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3238691-rigels-fostamatinib-still-positive-in-late-stage-extension-study-shares-ahead-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238689\" data-ts=\"1485785940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238689-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MAGS' title='Magal Security Systems Ltd.'>MAGS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/XXIA' title='Ixia'>XXIA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ARLP' title='Alliance Resource Partners, L.P.'>ARLP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BANC' title='Banc of California, Inc.'>BANC</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='red'>-56%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VIAV' title='Viavi Solutions Inc.'>VIAV</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3238689\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$CALA $EYEG $ESES-OLD - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3238689-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3238689-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238683\" data-ts=\"1485785295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238683-delta-lower-recovers-from-systems-outage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta lower as it recovers from systems outage</a></h4><ul> <li>Shares of Delta Air Line (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) are lower in premarket trading amid computer system issues at the company.</li> <li>The airline canceled 80 flights scheduled for today as it continues to recover from an outage.</li> <li>President Trump <a href=\"https://twitter.com/realDonaldTrump/status/826041397232943104\" target=\"_blank\">tweeted</a> earlier today that the disruptions at U.S. airports were related to Delta's computer outage and not protests over the administation's travel ban.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238565-delta-lifts-freeze-domestic-departures\" target=\"_blank\">Delta lifts freeze on domestic departures</a> (Jan. 30)</li> <li>DAL <font color='red'>-1.69%</font> premarket to $48.86.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3238683\" data-linked=\"Delta lower as it recovers from systems outage\" data-tweet=\"$DAL - Delta lower as it recovers from systems outage https://seekingalpha.com/news/3238683-delta-lower-recovers-from-systems-outage?source=tweet\" data-url=\"https://seekingalpha.com/news/3238683-delta-lower-recovers-from-systems-outage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238682\" data-ts=\"1485785177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238682-netapp-upgraded-to-buy-goldman-sachsplus-3_02\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp upgraded to Buy at Goldman Sachs; +3.02%</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+NetApp+%28NTAP%29+to+Buy/12471377.html\" target=\"_blank\">Analyst Simona Jankowski</a>, raising rating from Neutral, notes expectation for NetApp's Q3 2017 quarter to represent a return to growth following 12 successive quarters of year-over-year declines. Attributes high all-flash array growth, better competitive positioning, greater IT spending and subsiding pricing pressure.</li><li>Models Q3 2017 EPS&nbsp;at $0.77 (consensus $0.74), Q4 2017 at $0.80 (consensus $0.77), FY 2018 at $3.03 (from $2.90, consensus $2.88) and FY 2019 at $3.20 (from $3.07, consensus $2.98).</li><li>Further views repatriation as a possible catalyst lending to increased buybacks and for the prospect to give potential buyers \"dry powder\" for M&amp;A.</li><li>NetApp (NASDAQ:<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>) target increased from $36 to $43 (pre-market $38.90).</li><li>Previously (November 17, 2016): <a href=\"https://seekingalpha.com/news/3225419-goldman-sachs-sidelined-netapp-despite-core-business-momentum\" target=\"_blank\">Goldman Sachs sidelined on NetApp despite core business momentum</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238682\" data-linked=\"NetApp upgraded to Buy at Goldman Sachs; +3.02%\" data-tweet=\"$NTAP - NetApp upgraded to Buy at Goldman Sachs; +3.02% https://seekingalpha.com/news/3238682-netapp-upgraded-to-buy-goldman-sachsplus-3_02?source=tweet\" data-url=\"https://seekingalpha.com/news/3238682-netapp-upgraded-to-buy-goldman-sachsplus-3_02\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238673\" data-ts=\"1485784611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APD\" target=\"_blank\">APD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238673-air-productsminus-1_5-baird-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Products -1.5% as Baird downgrades</a></h4><ul><li>Air Products &amp;&nbsp;Chemicals (NYSE:<a href='https://seekingalpha.com/symbol/APD' title='Air Products and Chemicals, Inc.'>APD</a>) <font color='red'>-1.5%</font> premarket as Baird <a href=\"http://www.streetinsider.com/Downgrades/Baird+Downgrades+Air+Products+%26+Chemicals+Inc.+%28APD%29+to+Neutral/12471701.html\" target=\"_blank\">downgrades</a> shares to Neutral from Outperform with a $140 price target, trimmed from $146, after the company <a href=\"https://seekingalpha.com/news/3238320-air-products-sees-q2-fy-2017-earnings-consensus\" target=\"_blank\">cut earnings guidance</a> for FQ2 and FY 2017.</li><li>Baird believes that with identifiable margin improvement catalysts having now substantially played out, APD is more exposed to the same sluggish global economic trends that have underpinned its more cautious thinking on Praxair.</li><li>However, the firm continues to view APD in high regard overall and expects excellent execution and capital  allocation to persist.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238673\" data-linked=\"Air Products -1.5% as Baird downgrades\" data-tweet=\"$APD - Air Products -1.5% as Baird downgrades https://seekingalpha.com/news/3238673-air-productsminus-1_5-baird-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3238673-air-productsminus-1_5-baird-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238672\" data-ts=\"1485784566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PULM\" target=\"_blank\">PULM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238672-pulmatrixs-direct-stock-offering-2_50-sinks-shares-down-24-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pulmatrix&#39;s direct stock offering at $2.50 sinks shares, down 24% premarket</a></h4><ul><li>Nano cap Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) slumps<font color='red'> 24%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16726457-pulmatrix-announces-5-million-registered-direct-offering\" target=\"_blank\">direct offering</a> of 2M shares of common stock at $2.50 to several institutional investors. Friday's close was $3.37.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238672\" data-linked=\"Pulmatrix&#39;s direct stock offering at $2.50 sinks shares, down 24% premarket\" data-tweet=\"$PULM - Pulmatrix&#39;s direct stock offering at $2.50 sinks shares, down 24% premarket https://seekingalpha.com/news/3238672-pulmatrixs-direct-stock-offering-2_50-sinks-shares-down-24-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3238672-pulmatrixs-direct-stock-offering-2_50-sinks-shares-down-24-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238671\" data-ts=\"1485784440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238671-freds-rallies-after-walgreens-rite-aid-merger-deadline-extended\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fred&#39;s rallies after Walgreens-Rite Aid merger deadline extended</a></h4><ul> <li>Shares of Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) are higher in premarket action after Walgreens and Rite Aid extend their merger agreement to July 31.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238666-walgreens-rite-aid-extend-merger-agreement\" target=\"_blank\">Walgreens and Rite Aid extend merger agreement</a> (Jan. 30)</li> <li>FRED <font color='green'>+6.02%</font> premarket to $14.96.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3238671\" data-linked=\"Fred&#39;s rallies after Walgreens-Rite Aid merger deadline extended\" data-tweet=\"$FRED - Fred&#39;s rallies after Walgreens-Rite Aid merger deadline extended https://seekingalpha.com/news/3238671-freds-rallies-after-walgreens-rite-aid-merger-deadline-extended?source=tweet\" data-url=\"https://seekingalpha.com/news/3238671-freds-rallies-after-walgreens-rite-aid-merger-deadline-extended\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238670\" data-ts=\"1485784221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCRX\" target=\"_blank\">OCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238670-oceras-lead-product-candidate-flunks-mid-stage-study-shares-plummet-59-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocera&#39;s lead product candidate flunks mid-stage HE study; shares plummet 59% premarket</a></h4><ul><li>Thinly traded nano cap Ocera Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a>) craters&nbsp;<font color='red'>59%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16726374-ocera-announces-top-line-results-phase-2b-study-hepatic-encephalopathy\" target=\"_blank\">announcement </a>that a Phase 2b clinical trial, STOP-HE, assessing lead product candidate OCR-002 (ornithine phenylacetate) in hospitalized patients with hepatic encephalopathy &#40;HE&#41; failed to beat placebo as measured by the time to improvement in HE symptoms, the primary endpoint (p=0.129). It also failed to differentiate itself from placebo in the secondary endpoint of median time to complete response in HE symptoms (p=0.361).</li><li>On the plus side, OCR-002-treated patients showed a statistically valid reduction in the time to achieve normal plasma ammonia levels versus placebo (p=0.028), an exploratory endpoint.</li><li>Despite the setback, the company says it still plans to advance OCR-002 into Phase 3 development.</li><li>Ornithine phenylacetate is an ammonia scavenger that reduces excess ammonia in patients with liver cirrhosis and acute liver failure. Elevated ammonia causes swelling in the brain producing symptoms of HE.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238670\" data-linked=\"Ocera&#39;s lead product candidate flunks mid-stage HE study; shares plummet 59% premarket\" data-tweet=\"$OCRX - Ocera&#39;s lead product candidate flunks mid-stage HE study; shares plummet 59% premarket https://seekingalpha.com/news/3238670-oceras-lead-product-candidate-flunks-mid-stage-study-shares-plummet-59-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3238670-oceras-lead-product-candidate-flunks-mid-stage-study-shares-plummet-59-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238668\" data-ts=\"1485784135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238668-select-comfort-turns-green-investors-reasssess\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Comfort turns green as investors reasssess</a></h4><ul><li>Alongside<a href=\"https://seekingalpha.com/news/3238614-tempur-sealy-terminates-mattress-firm-contracts\" target=\"_blank\"> the termination</a> of its contracts with Mattress Firm, Tempur Sealy (NYSE:<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a>) also announced strong Q4 numbers - $770M in revenue vs. $740M expected, and EBITDA of $135M-$138M vs. $130M expected.</li><li>Absent the Mattress Firm news, TPX might be&nbsp;<font color='green'>higher by 10%</font>&nbsp;on those numbers, <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">suspects Notable Calls</a>, and Select Comfort (SCSS) - with zero exposure to Mattress Firm - might be&nbsp;<font color='green'>higher by 5%</font>.</li><li>Down sharply earlier, SCSS has rebounded to a&nbsp;<font color='green'>1% advance</font>&nbsp;in premarket action. TPX remains&nbsp;<font color='red'>lower by 23%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238668\" data-linked=\"Select Comfort turns green as investors reasssess\" data-tweet=\"$TPX $TPX $SNBR - Select Comfort turns green as investors reasssess https://seekingalpha.com/news/3238668-select-comfort-turns-green-investors-reasssess?source=tweet\" data-url=\"https://seekingalpha.com/news/3238668-select-comfort-turns-green-investors-reasssess\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238667\" data-ts=\"1485783718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238667-himax-technologies-downgraded-to-neutral-bairdminus-3_14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies downgraded to Neutral at Baird; -3.14%</a></h4><ul><li>From Outperform previously.</li><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Baird+Downgrades+Himax+Technologies+%28HIMX%29+to+Neutral/12471294.html\" target=\"_blank\">Analyst Tristan Gerra</a>: \"China panel makers are expected to start adopting gate-in-panel technology this year, which would reduce driver IC content. Himax's in-cell touch design has been delayed, while OLED ramp at China-based panel makers is not expected until 2019. AR/VR longer-term secular growth trends remain intact despite well-advertised&nbsp;program postponement impacting 2017.\"</li><li>Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) target reduced from $10 to $4 (pre-market $5.24).</li></ul><div class=\"tiny-share-widget\" data-id=\"3238667\" data-linked=\"Himax Technologies downgraded to Neutral at Baird; -3.14%\" data-tweet=\"$HIMX - Himax Technologies downgraded to Neutral at Baird; -3.14% https://seekingalpha.com/news/3238667-himax-technologies-downgraded-to-neutral-bairdminus-3_14?source=tweet\" data-url=\"https://seekingalpha.com/news/3238667-himax-technologies-downgraded-to-neutral-bairdminus-3_14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238660\" data-ts=\"1485782981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238660-gol-linhas-on-move-after-traffic-update-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gol Linhas on the move after traffic update, upgrade</a></h4><ul> <li>Gol Linhas (NYSE:<a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas Aéreas Inteligentes S.A.'>GOL</a>) says consolidated passenger revenue per available seat kilometers increased 6.5% to 6.8% in Q4. The company expects an operating margin of 6.5% to 7.0% for the quarter.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1291733/000129281417000171/gol20170130_6k.htm\" target=\"_blank\">SEC Form 6-K</a></li> <li>On Wall Street, Bank of America Merrill Lynch raises GOL Linhas to a Buy rating.</li>  <li>GOl <font color='green'>+2.49%</font> premarket to $19.73.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3238660\" data-linked=\"Gol Linhas on the move after traffic update, upgrade\" data-tweet=\"$GOL - Gol Linhas on the move after traffic update, upgrade https://seekingalpha.com/news/3238660-gol-linhas-on-move-after-traffic-update-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3238660-gol-linhas-on-move-after-traffic-update-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238659\" data-ts=\"1485782978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDP\" target=\"_blank\">HDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238659-hortonworks-upgraded-to-buy-mizuho-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hortonworks upgraded to Buy at Mizuho Securities</a></h4><ul><li>From Neutral, <a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Upgrades+Hortonworks+%28HDP%29+to+Buy/12471341.html\" target=\"_blank\">analyst&nbsp;</a><a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Upgrades+Hortonworks+%28HDP%29+to+Buy/12471341.html\" target=\"_blank\">Abhey Lamba</a> observes ongoing strength of industry adoption, improving pricing climate and notes easing of firm's prior execution and long-term bookings mix concerns.</li><li>Views possible upside to 2017 estimates, anticipates Q4 2016 above expectations and considers risk/reward appealing at current 2x EV/sales level.</li><li>Hortonworks (NASDAQ:<a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a>) price target increased from $10 to $12 (pre-market $9.12,&nbsp;<font color='green'>+2.47%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3238659\" data-linked=\"Hortonworks upgraded to Buy at Mizuho Securities\" data-tweet=\"$HDP - Hortonworks upgraded to Buy at Mizuho Securities https://seekingalpha.com/news/3238659-hortonworks-upgraded-to-buy-mizuho-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3238659-hortonworks-upgraded-to-buy-mizuho-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238649\" data-ts=\"1485781877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238649-berenberg-downgrades-barclays-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berenberg downgrades Barclays to Sell</a></h4><ul><li>It's been a&nbsp;<font color='green'>near-60% run higher&nbsp;</font>for Barclays (NYSE:<a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a>) since the post-Brexit vote panic. Analyst Peter Richardson downgrades to Sell from Hold, saying a lot of good news has been baked into the shares.</li><li>Source: <a href=\"http://thefly.com/permalinks/entry.php/id2495927/BCS-Barclays-rating-change-at-Berenberg\" target=\"_blank\">TheFly</a></li><li>The ADRs are&nbsp;<font color='red'>lower by 2.4%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238649\" data-linked=\"Berenberg downgrades Barclays to Sell\" data-tweet=\"$BCS - Berenberg downgrades Barclays to Sell https://seekingalpha.com/news/3238649-berenberg-downgrades-barclays-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3238649-berenberg-downgrades-barclays-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238633\" data-ts=\"1485780679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGEN\" target=\"_blank\">FGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238633-fibrogens-roxadustat-successful-in-two-late-stage-studies-in-china-shares-up-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FibroGen&#39;s roxadustat successful in two late-stage studies in China; shares up 9% premarket</a></h4><ul><li>FibroGen (NASDAQ:<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a>) is ahead&nbsp;<font color='green'>9%&nbsp;</font>premarket, albeit on only 100 shares, in response to its <a href=\"https://seekingalpha.com/pr/16726385-fibrogen-s-roxadustat-fgminus-4592-meets-primary-endpoints-two-phase-3-anemia-studies-china\" target=\"_blank\">announcement </a>of positive top-line results from two Phase 3 studies in China assessing roxadustat for the treatment of anemia in dialysis-dependent and non-dialysis dependent patients with chronic kidney disease. Both trials met their primary endpoints. The data will support a marketing application there.</li><li>If approved, collaboration partner AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) will commercialize while FibroGen will be responsible for manufacturing and medical affairs.</li><li>Roxadustat is an orally administered small molecule inhibitor of&nbsp;<a href=\"https://en.wikipedia.org/wiki/Hypoxia-inducible_factors\" target=\"_blank\">hypoxia-inducible factor</a>&nbsp;&#40;HIF&#41; prolyl hydroxylase. HIF is a protein transcription factor that \"turns on\" the production of red blood cells (erythropoiesis). Its value proposition is the ability to maintain hemoglobin levels in CKD patients without affecting inflammation and potentially avoiding the need for ongoing intravenous iron repletion therapy as needed with epoetin alfa&nbsp;(Janssen's <a href=\"http://www.procrit.com/\" target=\"_blank\">Procrit</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3238633\" data-linked=\"FibroGen&#39;s roxadustat successful in two late-stage studies in China; shares up 9% premarket\" data-tweet=\"$FGEN $FGEN $AZN - FibroGen&#39;s roxadustat successful in two late-stage studies in China; shares up 9% premarket https://seekingalpha.com/news/3238633-fibrogens-roxadustat-successful-in-two-late-stage-studies-in-china-shares-up-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3238633-fibrogens-roxadustat-successful-in-two-late-stage-studies-in-china-shares-up-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238629\" data-ts=\"1485780288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XXIA\" target=\"_blank\">XXIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238629-keysight-technologies-to-buy-ixia-for-1_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight Technologies to buy Ixia for $1.6B</a></h4><ul>     <li>Ixia (NASDAQ:<a href='https://seekingalpha.com/symbol/XXIA' title='Ixia'>XXIA</a>) <font color='green'>+5.7%</font> premarket after Keysight Technologies (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a>) <a href=\"https://seekingalpha.com/pr/16726335-keysight-ixia-combine-accelerate-growth-create-powerful-innovation-engine\" target=\"_blank\">agrees to  acquire</a> the company for ~$1.6B, or $19.65/share, a deal the companies say will create a technology business that spans electronic design, device and network validation, and application and security performance.</li>     <li>The deal values Ixia at $19.65/share, an 8% premium to Friday&rsquo;s closing price and 45% above the Dec. 1 price, the day before <a href=\"https://seekingalpha.com/news/3228369-ixia-plus-8-percent-exploration-strategic-alternatives-reported-updated\" target=\"_blank\">initial media reports</a> that Ixia was considering strategic alternatives.</li>     <li>KEYS expects revenue synergies of more than $50M by year three and $100M by year five from the deal, as well as annual cost synergies of $60M, of which $50M should be achieved within 24 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238629\" data-linked=\"Keysight Technologies to buy Ixia for $1.6B\" data-tweet=\"$XXIA $XXIA $KEYS - Keysight Technologies to buy Ixia for $1.6B https://seekingalpha.com/news/3238629-keysight-technologies-to-buy-ixia-for-1_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3238629-keysight-technologies-to-buy-ixia-for-1_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238622\" data-ts=\"1485779462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALA\" target=\"_blank\">CALA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238622-cithera-bio-up-35-premarket-on-partnership-incyte-to-develop-cbminus-1158\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cithera Bio up 35% premarket on partnership with Incyte to develop CB-1158</a></h4><ul><li>Thinly traded nano cap Calithera Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a>) is up&nbsp;<font color='green'>35%</font>&nbsp;premarket, albeit on only 750 shares, in response to its <a href=\"https://seekingalpha.com/pr/16726333-incyte-calithera-biosciences-announce-global-collaboration-develop-commercialize-cbminus-1158\" target=\"_blank\">announcement </a>of a global collaboration and license agreement with Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) research, develop and commercialize CB-1158 in hematology and oncology.</li><li>Under the terms of the agreement, Calithera will receive $45M upfront, up to $430M in milestones and tiered royalties from low- to mid-double digits. Incyte will also make an $8M investment in Calithera via the purchase of common stock at $4.65 per share (Friday's close was $4.60). Development costs will be funded on a 70/30 basis with Incyte paying the majority share. U.S. profit and losses will be shared on a 60/40 basis (greater share to Incyte). Calithera will have co-promotion (detailing) rights in the U.S.</li><li>CB-1158 inhibits an enzyme called arginase that is found in myeloid-derived suppressor cells which plays a key role in suppressing the immune system's anti-tumor activity. Specifically, it depletes the amino acid arginine in the tumor microenvironment and prevents the activation of the immune system's cytotoxic T cells and NK (natural killer) cells.</li><li>Incyte will have global rights to CB-1158 for hematology and oncology while Calithera will retain the rights to certain other arginase inhibitors in certain orphan indications. It also has the right to opt out of its co-funding obligations and instead receive up to $750M in milestones instead of a share of the future U.S. profits and losses (in addition to tiered low-to-mid-double-digit royalties).</li></ul><div class=\"tiny-share-widget\" data-id=\"3238622\" data-linked=\"Cithera Bio up 35% premarket on partnership with Incyte to develop CB-1158\" data-tweet=\"$CALA $CALA $INCY - Cithera Bio up 35% premarket on partnership with Incyte to develop CB-1158 https://seekingalpha.com/news/3238622-cithera-bio-up-35-premarket-on-partnership-incyte-to-develop-cbminus-1158?source=tweet\" data-url=\"https://seekingalpha.com/news/3238622-cithera-bio-up-35-premarket-on-partnership-incyte-to-develop-cbminus-1158\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238620\" data-ts=\"1485779173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRO\" target=\"_blank\">FRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238620-frontline-proposes-combination-dht\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontline proposes combination with DHT</a></h4><ul> <li>Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>)&nbsp;confirms it&nbsp;approached DHT Holdings (NYSE:<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a>) with a proposal for a possible business combination.</li>   <li>The company offered to acquire all outstanding shares of DHT in a stock-for-stock transaction at a ratio of 0.725 Frontline shares for each DHT share.</li><li>Frontline has already acquired 15,356,009 shares of DHT, representing ~16.4% of outstanding shares.</li>     <li>A combination of Frontline and DHT would create the largest public tanker company by fleet size, market cap and trading liquidity.</li><li>DHT&nbsp;<font color='green'>+16.16%</font>&nbsp;premarket to $4.96. FRO&nbsp;<font color='green'>+0.14%</font>&nbsp;to $7.03.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16726269-fro-frontline-initial-discussions-dht-holdings-inc-possible-business-combination\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3238620\" data-linked=\"Frontline proposes combination with DHT\" data-tweet=\"$FRO $FRO $DHT - Frontline proposes combination with DHT https://seekingalpha.com/news/3238620-frontline-proposes-combination-dht?source=tweet\" data-url=\"https://seekingalpha.com/news/3238620-frontline-proposes-combination-dht\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>127&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238619\" data-ts=\"1485778823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238619-dicks-sporting-goods-on-move-after-goldman-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s Sporting Goods on the move after Goldman nod</a></h4><ul> <li>Goldman Sachs lifts Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>) to a Buy rating from Neutral.</li> <li>DKS <font color='green'>+2.32%</font> premarket to $52.50 vs. a 52-week trading range of $36.06 to $62.88.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3238619\" data-linked=\"Dick&#39;s Sporting Goods on the move after Goldman nod\" data-tweet=\"$DKS - Dick&#39;s Sporting Goods on the move after Goldman nod https://seekingalpha.com/news/3238619-dicks-sporting-goods-on-move-after-goldman-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3238619-dicks-sporting-goods-on-move-after-goldman-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238617\" data-ts=\"1485778575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238617-baml-sees-upside-for-mercadolibre\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sees upside for Mercadolibre</a></h4><ul> <li>Bank of America Merrill Lynch moves to a Buy stance on Mercadlibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) after having the e-commerce stock rated at Neutral.</li> <li>The firm sets a price target of $210 to rep 15% upside potential.</li> <li>MELI <font color='green'>+1.02%</font> premarket to $184.50.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3238617\" data-linked=\"BAML sees upside for Mercadolibre\" data-tweet=\"$MELI - BAML sees upside for Mercadolibre https://seekingalpha.com/news/3238617-baml-sees-upside-for-mercadolibre?source=tweet\" data-url=\"https://seekingalpha.com/news/3238617-baml-sees-upside-for-mercadolibre\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3238568\" data-ts=\"1485763379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSYY\" target=\"_blank\">TOSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3238568-trust-banks-likely-to-sue-toshiba\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trust banks likely to sue Toshiba</a></h4><ul><li>Shares of Toshiba (<a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) <font color='red'>tumbled as much as 5.8%</font> overnight on word that some trust banks are <a href=\"http://www.daijiworld.com/news/newsDisplay.aspx?newsID=435099\" target=\"_blank\">preparing</a> to sue the company over its 2015 accounting scandal.</li><li>Separate reports suggested Chairman Shigenori Shiga was ready to step down and Toshiba would no longer accept orders for new atomic plants, withdrawing from its nuclear power business in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3238568\" data-linked=\"Trust banks likely to sue Toshiba\" data-tweet=\"$TOSYY $TOSBF - Trust banks likely to sue Toshiba https://seekingalpha.com/news/3238568-trust-banks-likely-to-sue-toshiba?source=tweet\" data-url=\"https://seekingalpha.com/news/3238568-trust-banks-likely-to-sue-toshiba\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}